Tepezza Hearing Loss MDL: Bellwether Trial Date Set In a significant development, the judge presiding over the Tepezza hearing loss MDL has established a pivotal date for the commencement of the first bellwether trial: March 9, 2026. Key Points: In conclusion, the establishment of the bellwether trial date and the collaborative efforts directed by Judge…
Tepezza Hearing Loss Litigation Update Throughout the month of April, the Tepezza hearing loss litigation maintained its trend of sluggish growth, with only 13 new cases added to the MDL. This brings the total number of cases in the Tepezza hearing loss MDL to a modest 113. Key Points: This update underscores the ongoing dynamics…
Update on Court Hearings and Submission Deadlines The status hearing originally planned for April 22, 2024, before the magistrate judge has been canceled. Instead, a joint status report, initially due on April 18, 2024, must now be submitted by April 24, 2024. Furthermore, an in-person status hearing before the Honorable Thomas M. Durkin is scheduled…
Florida Man Files Lawsuit Alleging Severe Injuries from Tepezza Infusions In a recent legal action, a Florida man has brought forth a lawsuit claiming that he suffered severe and permanent injuries due to infusions of Tepezza, a medication used to treat thyroid eye disease. According to the lawsuit, the man was diagnosed with the eye…
Horizon Requests Extension for Case Selection On March 13, 2024, lawyers representing Horizon in the Tepezza lawsuit filed a request to the MDL judge seeking a two-month extension for selecting four lawsuits related to Tepezza hearing loss for early bellwether discovery and potential trial preparation. The company cited the ongoing review of medical records as…
In February 2024, the Multidistrict Litigation (MDL) had 74 pending Tepezza cases, all in early stages without scheduled trials or settlements yet approved by the court. These lawsuits stem from allegations that Horizon Therapeutics, the manufacturer of Tepezza, failed to adequately warn about health risks associated with the drug, leading to permanent hearing loss or…
Frequent and Severe Tepezza Adverse Effects Tepezza can trigger a range of side effects, both common and severe, necessitating careful consideration before usage. Tepezza Side Effects The drug’s common side effects encompass a spectrum of issues like nausea, diarrhea, fatigue, muscle spasms, dry skin, taste alterations, and menstrual irregularities. Serious side effects include infusion reactions,…
Lawsuits against Horizon Therapeutics, the manufacturer of Tepezza, allege a failure to adequately warn doctors and patients about potential health risks. Individuals who have experienced permanent hearing loss or tinnitus after taking Tepezza are pursuing legal action. Here are the latest developments in Tepezza litigation: Recent Tepezza Lawsuit Updates As of October 2023, there…
Overview of Tepezza Lawsuits Against Horizon Therapeutics USA Inc. Ireland-based pharmaceutical company Horizon Therapeutics USA Inc. is currently facing lawsuits in the United States from patients who claim that Tepezza, its thyroid eye disease drug, caused them to experience permanent hearing loss or tinnitus. Tepezza: The First FDA-Approved Drug for Thyroid Eye Disease Tepezza, known…